Mocetinostat (MGCD0103)


  • Specification
  • Related Products
Cat.No.:  BSM-0169
Product Name:  Mocetinostat (MGCD0103)
CAS No.:  726169-73-9
Figure: 
Synonyms:  N-(2-Aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]benzamide; Mocetinostat; MG0103
Description:  Mocetinostat (MGCD0103) selectively inhibits histone deacetylases (HDACs) 1-3 and 11 at submicromolar concentrations. (IC50 = 0.15, 0.29, 1.66 and 0.59 µM for HDAC1, 2, 3 and 11 respectively). Mocetinostat induces hyperacetylation of histones, causes expression of the tumor suppressor protein p21(WAF1/CIP1), and inhibits proliferation of human cancer cells growing in culture.
Appearance:  White to off-white solid
Molecular Weight:  396.44
Purity:  >98% by HPLC
Storage:  -20 ̊C
Targets:  Class I HDAC
Molecular Formula:  C23H20N6O
MDL Number:  MFCD03453554
Solubility:  DMSO
Shipping Conditions:  Gel Pack
Warning:  For Research Use Only! Not For Use in Humans.

Online Inquiry

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

USA

Enter your email here to subscribe.

Follow us on

Easy access to products and services you need from our library via powerful searching tools

Copyright © Creative BioMart. All Rights Reserved.